SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is experiencing significant buzz driven by its recent announcement of strengthening financials through the elimination of convertible debt. The community is actively discussing the potential for a substantial short squeeze, fueled by exceptionally high borrowing costs and limited share availability, especially given the company's vocal stance against short selling. This dynamic, combined with its innovative authentication technology and low share float, is sparking intense speculation about a major upward movement.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as the Department of Justice's criminal investigation into Fed Chair Jerome Powell ignites widespread debate, with Powell asserting the probe is political retaliation over interest rate decisions. This unprecedented situation fuels community concerns about the Federal Reserve's independence and potential market volatility, while others view it as a buying opportunity amidst broader geopolitical tensions. Precious metals are notably surging as investors seek safe havens.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a top trending stock following positive FDA feedback, which significantly de-risking the regulatory pathway for its lead asset, Sonelokimab, in hidradenitis suppurativa. The community is actively discussing strong analyst upgrades and the high potential for a major pharmaceutical acquisition, with many seeing the company as a key player in the immunology space. Despite widespread bullish sentiment and confidence in the drug's "best-in-class" potential, some investors are noting perceived price suppression, fueling expectations for further upside.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is surging amidst widespread discussion following President Trump's public praise for CEO Lip-Bu Tan and the company's new U.S.-designed and built sub-2 nanometer CPU processors, emphasizing the substantial returns on the government's investment. The community is actively debating whether this momentum, driven by national security priorities and the 18A process, signals a fundamental turnaround and significant future partnerships or if current gains are merely a 'Trump pump' ahead of potential major announcements.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as a major beneficiary of renewed crypto market optimism, fueled by recent analyst upgrades and increasing institutional interest. The community is actively discussing its strong correlation with Bitcoin's momentum, anticipation around regulatory clarity, and the company's strategic expansion into an 'everything exchange' with new tokenization and trading products.

Monero

Monero (XMR) is trending as the crypto community highlights its superior privacy features, positioning it as the 'real privacy king' amidst ongoing discussions about the shortcomings of other privacy tokens. Many are discussing XMR's consistent strength and outperformance, viewing it as a resilient asset aligned with crypto's original decentralized vision. This renewed focus on true financial privacy, despite its limited availability on major exchanges, is fueling bullish sentiment and anticipation for significant price appreciation.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is drawing significant attention amid intensifying speculation about potential U.S. strategic interest in Greenland's vast critical mineral resources, particularly its Tanbreez project, ahead of imminent diplomatic discussions. The community is highly bullish, anticipating substantial appreciation as geopolitical dynamics underscore the urgent need for secure rare earth supply chains, also fueling discussions of a potential short squeeze.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is trending after announcing significant revenue growth for its lead oncology product, OJEMDA, and providing optimistic future projections that have surpassed analyst expectations. This positive performance, coupled with a strategic acquisition to bolster its ADC pipeline, has fueled widespread community discussion around its intrinsic value and potential as an M&A target in the consolidating biotech landscape.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amid intense scrutiny following new competitive entries, such as Amazon Pharmacy's push into the oral GLP-1 market, alongside ongoing regulatory concerns and a recent analyst downgrade. While many express bearish sentiment over its competitive moat, a strong counter-narrative emphasizes the company's long-term vision in personalized healthcare, vertical integration, and AI initiatives, prompting some to view the current price action as a unique buying opportunity.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is a top trending stock following the completion of enrollment in a pivotal maintenance dosing study for its VK2735 obesity treatment and the strategic appointment of a Chief Commercial Officer from Eli Lilly. The community eagerly anticipates the upcoming J.P. Morgan conference, looking for updates on the oral program's regulatory path and potential partnerships for its "best-in-class" dual GLP-1/GIP agonist. While optimists highlight strong clinical data and a vast market, skepticism persists regarding management's strategy amid intense competition and significant short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tempus AI Stock Surges 82.4% in a Year: What's Driving It?

TEM shares are up 82.4% in a year as Genomics revenues surge, Data & Services scale, FDA clearances and EBITDA turns positive.

Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO Gastrointestinal Cancers Symposium

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO...

TEM's Stable Solvency and Financial Strength Are Gaining Attention

Tempus AI posts a strong Q3 2025 balance sheet with $760M cash, no current debt, and positive adjusted EBITDA, boosting flexibility and solvency.

Best Healthcare Stocks To Follow Today - January 6th

UnitedHealth Group, Johnson & Johnson, Intuitive Surgical, Medtronic, Tempus AI, Novartis, and Hims & Hers Health are the seven Healthcare stocks to watch today, according to MarketBeat's stock...

Best Artificial Intelligence Stocks To Watch Now - January 6th

Tempus AI, BigBear.ai, and Hut 8 are the three Artificial Intelligence stocks to watch today, according to MarketBeat's stock screener tool. Artificial intelligence stocks are shares of companies...

Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place...

Cathie Wood Loads Up On Tempus AI And This George Soros-Backed Company's Stock, Dumps Roku And Shopify Shares

On Monday, Jan. 5, 2026, Cathie Wood-led ark purchased Tempus AI and Kodiak AI shares while selling Roku and Shopify stockread more...

Tempus AI's Options Frenzy: What You Need to Know

Best Healthcare Stocks To Consider - January 5th

UnitedHealth Group, Johnson & Johnson, Hims & Hers Health, McKesson, Intuitive Surgical, HCA Healthcare, and Tempus AI are the seven Healthcare stocks to watch today, according to MarketBeat's stock...

Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization

HIMS deepens its AI and data strategy with personalized care tools, biomarker tracking, and smarter treatment matching.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

TEM
Tempus AI Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TEM News

TEMTempus AI Inc